Cardiomyopathy Trial, Recruiting NCT06371937 Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06371937
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 80 years of age
  • People who have been diagnosed with Cardiovascular Disease (a condition affecting the heart and blood vessels)
  • People who have been diagnosed with Cerebrovascular Disease (a condition affecting blood flow to the brain)
  • People who have been diagnosed with Peripheral Vascular Disease (a condition affecting blood vessels outside the heart and brain, often in the legs)
  • People who have been diagnosed with Inherited Arrhythmias (irregular heart rhythms passed down through families)
  • People who have been diagnosed with Cardiomyopathies (diseases affecting the heart muscle)
  • People who have been diagnosed with Congenital Heart Disease (heart conditions present from birth)
  • People who have been diagnosed with Aortopathy (a condition affecting the aorta, the main artery carrying blood from the heart)
  • People who have been diagnosed with Hypertension (high blood pressure)
  • People who have been diagnosed with Cardiometabolic Disease (conditions involving both heart health and metabolism, such as diabetes combined with heart-related risk factors)

Who may not be able to join:

  • People under 18 years of age
  • People who are not able to give their own consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
30 June 2033

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

REDCap Database; Induced pluripotent stem cell (iPSC) Biobank; Differentiation into Cardiovascular lineages; Molecular profiling of participants; Bioinformatics analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov